Grant & Eisenhofer named lead counsel in Quantum BioPharma suit
Quantum BioPharma said the U.S. District Court appointed Grant & Eisenhofer as lead counsel in a lawsuit alleging CIBC and RBC manipulated the company’s stock.
Story updates
03:07:03 PM UTC
SquawkNews
Quantum BioPharma said SDNY consolidated its direct action and a related class action alleging spoofing in QNTM shares, and appointed Grant & Eisenhofer as lead counsel. The court made no findings on liability or damages.Material DetailsContext by AI AnalystThis is an early procedural milestone in…